This project has been archived.
Impurity Control Working Group
The mission of the Impurity Control WG was to formulate an industry position for organic impurities from fermentation and semi-synthetic derived drug substance, peptide and peptide conjugates, and antibody-drug conjugates.
The group had two active subgroups. The first was focused on the small molecule impurities in anti-body drug conjugates and the second was focused on impurities as they relate to oligonucleotides.